CTOs on the Move

North American Dental Group

www.nadentalgroup.com

 
North American Dental Group is a premier dental group with a commitment to industry-leading service and care for EVERY PATIENT, EVERY VISIT. We have a true partnership with our affiliated dentists enabling them to focus on what they do best and love most… dentistry. With our patient-centric approach, our mission is to serve our doctors and their clinical support teams so they have clinical autonomy to provide the very best treatment focused on EMPATHY, COMPASSION and CARE. We provide comprehensive support to 260+ dental practices with the understanding that it requires the efforts of everyone to achieve our goals for ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Dan Romary
 Chief Information Officer Profile
Vitarin Buranakarn
 Director of IT Program Management Profile

Similar Companies

Oral Health Products

Oral Health Products is a Tulsa, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ROWI

ROWI Teen is a mental health treatment center for teens and adolescents, specializing in mental health issues like depression, anxiety, OCD, and ASD.

The ALARIS Group

The ALARIS Group is a Duluth, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PROJECTFOREVER

YOUR BEST BODY. YOUR BEST LIFE. PROJECTFOREVER IS DEDICATED TO HELPING PEOPLE DO WHAT THEY LOVE AT THEIR HIGHEST POTENTIAL, FREE OF PAIN, FOR AS LONG AS THEY LIVE. With thousands of “impossible” transformations and counting, our proven approach to fitn...

Diagnocure

DiagnoCure (TSX: CUR; OTCQX: DGCRF) is a life sciences corporation that develops and commercializes high-value cancer diagnostic tests that increase clinician and patient confidence in making critical treatment decisions. In 2008, the Corporation launched a colorectal cancer staging test through its U.S. CLIA laboratory. PrevistageTM GCC is currently available for licensing. The Corporation has granted a worldwide exclusive license on the diagnostic applications of its proprietary molecular biomarker PCA3 to Gen-Probe, now a wholly-owned subsidiary of Hologic Inc. Hologic Gen-Probe's PROGENSA® PCA3 prostate cancer test is commercialized in Europe under CE mark and is approved for commercialization in Canada and the United States.